Table 4.

Percentage of populations of viable and non‑viable cells exhibiting structural properties of different cell death types following exposure to different groups of nanoliposomes for 24 h

Treatment group	Viable cells	Non-viable cells
		Necrosis	Late apoptosis	Early apoptosis
Untreated cells	91.56 ± 0.87	2.65 ± 0.16	4.52 ± 0.72	1.26 ± 0.12
HRZ	90.83 ± 1.65	1.04 ± 0.20	4.48 ± 1.31	3.64 ± 0.55
HRZ/siNC	91.36 ± 1.27	1.45 ± 0.84	3.83 ± 0.60	3.36 ± 0.32
HRZ/siTGF-β1 (35 mg/ml)	84.16 ± 1.53**	1.77 ± 0.29	9.56 ± 0.51	4.48 ± 1.28
HRZ/siTGF-β1 (40 mg/ml)	78.53 ± 1.13**	2.74 ± 0.39	12.50 ± 0.75	6.20 ± 1.16

The results are presented as the average percentage of the cell population (%) ± standard deviation; *P < 0.05 *, *P < 0.01 vs. untreated cells